Tadahide Noguchi

Dr. Tadahide Noguchi

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2006 in Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology
Verified
Journal Article
Closed access
TNTadahide Noguchi
Tadahide Noguchi
YJYoshinori Jinbu
Yoshinori Jinbu
HIHiroto Itoh
Hiroto Itoh
KMKoichi Matsumoto
Koichi Matsumoto
OSOsamu Sakai
Osamu Sakai
MKMikio Kusama
Mikio Kusama

15 March 2021 in International Journal of Clinical Oncology
Verified
Journal Article
Open access
PDF file
YOYoshihide Ota
Yoshihide Ota
TNTadahide Noguchi
Tadahide Noguchi
EAEiichiro Ariji
Eiichiro Ariji
CFChihiro Fushimi
Chihiro Fushimi
NFNobukazu Fuwa
Nobukazu Fuwa
TKTadaaki Kirita
Tadaaki Kirita
For doctors and other medical staff treating oral cancer, it is necessary to standardize the basic concepts and rules for oral cancer to achieve progress in its treatment, research, and diagnosis. Oral cancer is an integral part of head and neck cancer and is treated in accordance with the general rules for head and neck cancer. However, detailed rules based on the specific characteristics of oral cancer are essential. The objective of this article was to contribute to the development of the diagnosis, treatment, and research of oral cancer, based on the correct and useful medical information of clinical, surgical, pathological, and imaging findings accumulated from individual patients at various institutions. Our general rules were revised as the UICC was revised for the 8th edition and were published as the Japanese second edition in 2019. In this paper, the English edition of the “Rules” section is primarily presented.

16 November 2017 in Chronobiology International
Verified
Journal Article
Closed access
YTYoshiyuki Tsuchiya
Yoshiyuki Tsuchiya
KUKentaro Ushijima
Kentaro Ushijima
TNTadahide Noguchi
Tadahide Noguchi
NONaruo Okada
Naruo Okada
JHJun-Ichi Hayasaka
Jun-Ichi Hayasaka
AFAkio Fujimura
Akio Fujimura
Docetaxel, cisplatin plus fluorouracil (DCF) regimen is a useful chemotherapy, but is sometimes withdrawn due to severe adverse effects (AE). In this study, we examined whether the chronotherapy of DCF regimen could reduce the drugs-induced toxicities in clinical practice. Patients with oral squamous cell carcinoma were enrolled. Chemotherapy started at 10:30 (Morning-dosing) or 18:30 (Evening-dosing) for 5 days by a cross-over design. AE were assessed for 14 days after an initiation of each dosing. The grades of nausea, vomiting and neutropenia were smaller during Evening-dosing than during Morning-dosing. These data suggest that the chrono-chemotherapy might provide a merit for reducing the DCF regimen-related severe AE.

14 February 2024 in Immunologic Research
Verified
Journal Article
Open access
PDF file
ADAkihiro Dohi
Akihiro Dohi
TNTadahide Noguchi
Tadahide Noguchi
MYMasako Yamashita
Masako Yamashita
KSKenichi Sasaguri
Kenichi Sasaguri
TYToshiharu Yamamoto
Toshiharu Yamamoto
YMYoshiyuki Mori
Yoshiyuki Mori
Acute restraint stress (RS) is routinely used to study the effects of psychological and/or physiological stress. We evaluated the impact of RS on cervical lymph nodes in rats at molecular and cellular levels. Male Sprague–Dawley rats were subjected to stress by immobilization for 30, 60, and 120 min (RS30, RS60, and RS120, respectively) and compared with rats of a no-stress control (C) group. The expression of genes encoding chemokines CXCL1/CXCL2 (Cxcl1 and Cxcl2) and their receptor CXCR2 (Cxcr2) was analyzed using reverse transcription-quantitative PCR (RT-qPCR) and microarray analyses. Immunohistochemistry and in situ hybridization were performed to determine the expression of these proteins and the macrophage biomarker CD68. Microarray analysis revealed that the expression of 514 and 496 genes was upregulated and downregulated, respectively, in the RS30 group. Compared with the C group, the RS30 group exhibited a 23.0-, 13.0-, and 1.6-fold increase in Cxcl1, Cxcl2, and Cxcr2 expression. Gene Ontology analysis revealed the involvement of these three upregulated genes in the cytokine network, inflammation, and leukocyte chemotaxis and migration. RT-qPCR analysis indicated that the mRNA levels of Cxcl1 and Cxcl2 were significantly increased in the RS30 group but were reverted to normal levels in the RS60 and RS120 groups. Cxcr2 mRNA level was significantly increased in the RS30 and RS120 groups compared with that in the C group. RS-induced CXCL1-immunopositive cells corresponded to B/plasma cells, whereas CXCL2-immunopositive cells corresponded to endothelial cells of the high endothelial venules. Stress-induced CXCR2-immunopositive cells corresponded to macrophages. Psychological and/or physiological stress induces an acute stress response and formation of an immunoreactive microenvironment in cervical lymph nodes, with the CXCL1/CXCL2–CXCR2 axis being pivotal in the acute stress response.

12 March 2019 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
TNTadahide Noguchi
Tadahide Noguchi
YSYasushi Sugiura
Yasushi Sugiura
NONaruo Okada
Naruo Okada
YTYoshiyuki Tsuchiya
Yoshiyuki Tsuchiya
JHJun-Ichi Hyasaka
Jun-Ichi Hyasaka
YMYoshiyuki Mori
Yoshiyuki Mori
Osteosarcomas of the head and neck region are rare entities that comprise < 10% of all osteosarcomas. Multimodality treatment of patients with osteosarcoma is well-established for osteosarcoma in long bones, and the benefits of chemotherapy in long bones are clearly known. However, there is no consensus regarding the effects of chemotherapy in cases of head and neck osteosarcoma. The prognostic factor for head and neck osteosarcoma is complete tumor resection with negative margin, which is a radical surgery. However, a clear margin may be difficult to achieve in the head and neck region. We present a case of a 69-year-old Japanese woman who developed osteosarcoma of the condyle within the masticator space and infratemporal fossa, which was treated with radical surgery using a modified preauricular and transmandibular approach. Although we recommended adjuvant treatment after surgery, the patient refused this treatment. There was no evidence of local recurrence or distant metastasis through 30 months of follow-up. Our modified preauricular and transmandibular approach allowed access to the masticator space and infratemporal fossa, thereby increasing complete resection of the tumor and resulting in minimal functional and cosmetic deficits.

1 August 2018 in International Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
TNTadahide Noguchi
Tadahide Noguchi
SSS. Sarukawa
S. Sarukawa
YTY. Tsuchiya
Y. Tsuchiya
NONoriki Okada
Noriki Okada
JHJ. Hayasaka
J. Hayasaka
YMY. Mori
Y. Mori